Viewing Study NCT06696768


Ignite Creation Date: 2025-12-24 @ 5:51 PM
Ignite Modification Date: 2025-12-25 @ 3:16 PM
Study NCT ID: NCT06696768
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module